Literature DB >> 30326990

Cross-sectional study on Asthma Insights and Management in the Gulf and Russia.

Ashraf Alzaabi1, Majdy Idrees2, Naser Behbehani3, Musa R Khaitov4, Kaan Tunceli5, Eduardo Urdaneta6, Nancy Awad7, Mohamed Safwat7.   

Abstract

Background: Asthma is a chronic and complex lung disease that is not completely understood. It involves airway inflammation, reversible airflow obstruction, and bronchial hyperresponsiveness. The most common symptoms are recurrent wheezing, chest tightness, shortness of breath, and coughing. Objective: The Asthma Insights and Management study gathered information on the burden of asthma in the Gulf region (United Arab Emirates, Kuwait, Saudi Arabia) and Russia.
Methods: This was a cross-sectional, multinational, noninterventional, two-phase study that collected data from patients ages ≥ 12 years, through interviews and a survey questionnaire. Phase 1 consisted of survey questions focused on estimating the asthma prevalence in the community. Phase 2 was designed to assess the level of asthma control, asthma-related perceptions and behaviors, and presentation patterns. Data were summarized by using descriptive analyses.
Results: Analysis of data of 711 patients revealed that the prevalence of asthma among patients who lived in the community was 7.9% and that 66% subjectively perceived their asthma as being controlled. However, 97% of the patients' asthma were partially controlled or uncontrolled based on the Global initiative for Asthma control classification. Troubling symptoms were daytime coughing (33.3%) and shortness of breath (20.3%). With respect to medications for asthma, 76.2% of the patients reported the use of quick relief medication and 80.8% of maintenance medication during the past 4 weeks. Asthma exacerbation in the past year was reported by 40% of adults and adolescents in the study.
Conclusion: The results showed that a significant proportion of the patients experienced bothersome symptoms and that many had a lack of knowledge about asthma control and treatment recommendations, which indicated that there is a need for improvements in patient education and asthma care in the Gulf and Russia regions.

Entities:  

Mesh:

Year:  2018        PMID: 30326990      PMCID: PMC6212633          DOI: 10.2500/aap.2018.39.4180

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  26 in total

1.  Prevalence and risk factors of asthma among adolescents and their parents in Al-Ain (United Arab Emirates).

Authors:  Shirina Alsowaidi; Abdishakur Abdulle; Roos Bernsen
Journal:  Respiration       Date:  2009-05-14       Impact factor: 3.580

2.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study.

Authors:  K F Rabe; P A Vermeire; J B Soriano; W C Maier
Journal:  Eur Respir J       Date:  2000-11       Impact factor: 16.671

3.  Level of asthma control and healthcare utilization in Latin America.

Authors:  L S Gold; F Montealegre; F C Allen-Ramey; J Jardim; N Smith; R Sansores; S D Sullivan
Journal:  Allergy       Date:  2013-10-10       Impact factor: 13.146

4.  Associations of patient outcomes with level of asthma control.

Authors:  Laura S Gold; Nancy Smith; Felicia C Allen-Ramey; Robert A Nathan; Sean D Sullivan
Journal:  Ann Allergy Asthma Immunol       Date:  2012-08-15       Impact factor: 6.347

5.  Asthma insights and reality in the United Arab Emirates.

Authors:  Bassam Hassan Saleh Hassan Mahboub; Sonia Santhakumar; Joan B Soriano; Ruby Pawankar
Journal:  Ann Thorac Med       Date:  2010-10       Impact factor: 2.219

6.  The level of specialist assessment of adult asthma is influenced by patient age.

Authors:  C Porsbjerg; A Sverrild; L Stensen; V Backer
Journal:  Respir Med       Date:  2014-07-18       Impact factor: 3.415

7.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

Authors:  Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

8.  Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey.

Authors:  David Price; Monica Fletcher; Thys van der Molen
Journal:  NPJ Prim Care Respir Med       Date:  2014-06-12       Impact factor: 2.871

9.  Relation between depression and sociodemographic factors.

Authors:  Noori Akhtar-Danesh; Janet Landeen
Journal:  Int J Ment Health Syst       Date:  2007-09-04

10.  Global strategies for reducing the burden from asthma.

Authors:  Onno C P van Schayck
Journal:  Prim Care Respir J       Date:  2013-06
View more
  5 in total

1.  Atopic dermatitis: A disease "More common in families that sneeze and wheeze".

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2018-11-01       Impact factor: 2.587

2.  Impact of refractory and unexplained chronic cough on disease burden: a qualitative study.

Authors:  Naoya Ueda; Anzu Yakushiji; Jonathan Schelfhout; Shigeru Tokita; Takekazu Kubo
Journal:  BMC Pulm Med       Date:  2022-10-01       Impact factor: 3.320

3.  Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational study.

Authors:  Ashraf Alzaabi; Nasser Al Busaidi; Rohit Pradhan; Fathelrahman Shandy; Naseem Ibrahim; Moulham Ashtar; Khaled Khudadah; Khaled Hegazy; Mohamed Samir; Mohamed Negm; Hisham Farouk; Arwa Al Khalidi; Maarten Beekman
Journal:  Asthma Res Pract       Date:  2022-07-07

Review 4.  Perspectives on decisions for treatment and care in severe asthma.

Authors:  Tonya Winders; Jorge Maspero; Luke Callan; Mona Al-Ahmad
Journal:  World Allergy Organ J       Date:  2021-01-16       Impact factor: 4.084

5.  Direct and Indirect Costs of Asthma Burden in Abu Dhabi: A Retrospective Analysis of Insurance Claims Data from 2015 to 2018.

Authors:  Khulood Al Mazrouei; Asma Ibrahim Almannaei; Faiza Medeni Nur; Nagham Bachnak; Ashraf Alzaabi
Journal:  Clinicoecon Outcomes Res       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.